EGFR and malignant glioma: In contrast, studies in highly invasive tumors such as osteosarcoma and malignant glioma have not reported activation of EGFR/MAPK by fibulin-3 but have shown instead direct activation of canonical TNF-alpha/NF-κB signaling (26, 36, 39).